Matthew Meyerson, M.D., Ph.D.
Professor of Pathology, Dana-Farber Cancer Institute & Harvard Medical School
Director, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute
Institute Member, Broad Institute of Harvard & MIT
American Cancer Society Research Professor
MD, Harvard Medical School, 1993
PhD, Harvard University, 1994
Phone | Email | Twitter
Dr. Meyerson and his laboratory uses genomic approaches to discover the causes of human diseases. Efforts are focused on discovering genetic changes that cause cancer and infectious agents that cause diseases of unknown origin.
Dr. Meyerson is a principal investigator in The Cancer Genome Atlas project (TCGA) of the National Institutes of Health and leads a Genome Characterization Center at the Broad Institute, focused on copy number alterations and chromosomal re-arrangements. He leads the lung cancer disease working group of TCGA and is co-chair of TCGA’s executive committee. Meyerson has co-led the manuscript team for TCGA’s first project on the glioblastoma genome; a study of the squamous cell lung carcinoma genome that identified the first somatic mutations of immune regulators in cancer.
A decade ago, a team led by Meyerson discovered frequent mutations in the epidermal growth factor receptor tyrosine kinase gene, EGFR, in lung adenocarcinomas. The EGFR mutations are tightly associated with clinical response to gefitinib and erlotinib, EGFR kinase inhibitors. This result helped to establish the paradigm where cancer treatment can be targeted directly at the molecular causes of the cancers. Working closely with colleagues in the Broad’s Cancer Program, the Meyerson group contributed to the discovery of other major cancer genes in lung, colon, and breast cancers, leukemias, and pediatric cancers, many with direct therapeutic implications.
As a principal investigator and mentor, my goals are to catalyze new fields of cancer research, and to mentor a new generation of cancer researchers.
“... Truth is not a colored bird to be chased among the rocks and captured by its tail, but a skeptical attitude towards life.” – Sinclair Lewis
Professor of Pathology, Dana-Farber Cancer Institute & Harvard Medical School
Director, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute
Institute Member, Broad Institute of Harvard & MIT
American Cancer Society Research Professor
MD, Harvard Medical School, 1993
PhD, Harvard University, 1994
Phone | Email | Twitter
Dr. Meyerson and his laboratory uses genomic approaches to discover the causes of human diseases. Efforts are focused on discovering genetic changes that cause cancer and infectious agents that cause diseases of unknown origin.
Dr. Meyerson is a principal investigator in The Cancer Genome Atlas project (TCGA) of the National Institutes of Health and leads a Genome Characterization Center at the Broad Institute, focused on copy number alterations and chromosomal re-arrangements. He leads the lung cancer disease working group of TCGA and is co-chair of TCGA’s executive committee. Meyerson has co-led the manuscript team for TCGA’s first project on the glioblastoma genome; a study of the squamous cell lung carcinoma genome that identified the first somatic mutations of immune regulators in cancer.
A decade ago, a team led by Meyerson discovered frequent mutations in the epidermal growth factor receptor tyrosine kinase gene, EGFR, in lung adenocarcinomas. The EGFR mutations are tightly associated with clinical response to gefitinib and erlotinib, EGFR kinase inhibitors. This result helped to establish the paradigm where cancer treatment can be targeted directly at the molecular causes of the cancers. Working closely with colleagues in the Broad’s Cancer Program, the Meyerson group contributed to the discovery of other major cancer genes in lung, colon, and breast cancers, leukemias, and pediatric cancers, many with direct therapeutic implications.
As a principal investigator and mentor, my goals are to catalyze new fields of cancer research, and to mentor a new generation of cancer researchers.
“... Truth is not a colored bird to be chased among the rocks and captured by its tail, but a skeptical attitude towards life.” – Sinclair Lewis
Julie Hammond-Coiro
Assistant to Dr. Matthew Meyerson, Group Administrator
Dana-Farber Cancer Institute
My goal is to make the world a better place one step, one smile, and one act of kindness at a time.
“You give but little when you give of your possessions. It is when you give of yourself that you truly give.” – Kahlil Gibran
617-632-4377 | Email
Assistant to Dr. Matthew Meyerson, Group Administrator
Dana-Farber Cancer Institute
My goal is to make the world a better place one step, one smile, and one act of kindness at a time.
“You give but little when you give of your possessions. It is when you give of yourself that you truly give.” – Kahlil Gibran
617-632-4377 | Email
|
|